NDC 0121-0744 – Guaifenesin
Guaifenesin 100 mg/5mL · Solution · Oral
Product NDC0121-0744
Product details
- Brand name
- Guaifenesin
- Generic name
- Guaifenesin
- Labeler
- PAI Holdings, LLC dba PAI Pharma
- Dosage form
- Solution
- Route
- Oral
- Marketing category
- OTC MONOGRAPH DRUG · M012
- Marketed since
- September 1, 2002
- Listing expires
- December 31, 2026
- Pharmacologic class
- Expectorant
Active ingredients
- Guaifenesin 100 mg/5mL
Package NDC codes (3)
| Package NDC | Description | Since |
|---|---|---|
| 0121-0744-04 | 118 mL in 1 BOTTLE (0121-0744-04) | Sep 1, 2002 |
| 0121-0744-08 | 237 mL in 1 BOTTLE (0121-0744-08) | Sep 1, 2002 |
| 0121-0744-16 | 473 mL in 1 BOTTLE (0121-0744-16) | Sep 1, 2002 |
Other Guaifenesin products
- 60687-852 Guaifenesin 100 mg/5mL · Solution · American Health Packaging
- 60687-874 Guaifenesin 300 mg/15mL · Solution · American Health Packaging
- 60687-863 Guaifenesin 200 mg/10mL · Solution · American Health Packaging
- 55154-9450 Guaifenesin 100 mg/5mL · Solution · Cardinal Health 107, LLC
- 55154-5780 Guaifenesin 200 mg/10mL · Solution · Cardinal Health 107, LLC
- 0121-1488 Guaifenesin 200 mg/10mL · Solution · PAI Holdings, LLC dba PAI Pharma
- 0121-1744 Guaifenesin 100 mg/5mL · Solution · PAI Holdings, LLC dba PAI Pharma
- 0121-2232 Guaifenesin 300 mg/15mL · Solution · PAI Holdings, LLC dba PAI Pharma
- 80513-413 Guaifenesin 1200 mg/1 · Tablet, Extended Release · Advanced Rx LLC
- 46122-750 Guaifenesin 600 mg/1 · Tablet, Extended Release · AMERISOURCE BERGEN
- 65162-037 Guaifenesin 1200 mg/1 · Tablet, Extended Release · Amneal Pharmaceuticals LLC
- 65162-036 Guaifenesin 600 mg/1 · Tablet, Extended Release · Amneal Pharmaceuticals LLC